247 related articles for article (PubMed ID: 28130580)
1. [What can/should be treated in kidney tumors and when].
Sommer CM; Vollherbst DF; Richter GM; Kauczor HU; Pereira PL
Radiologe; 2017 Feb; 57(2):80-89. PubMed ID: 28130580
[TBL] [Abstract][Full Text] [Related]
2. Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation.
Sommer CM; Pallwein-Prettner L; Vollherbst DF; Seidel R; Rieder C; Radeleff BA; Kauczor HU; Wacker F; Richter GM; Bücker A; Rodt T; Massmann A; Pereira PL
Eur J Radiol; 2017 Jan; 86():143-162. PubMed ID: 28027741
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Thermal Ablation for Treatment of T1a Renal Cell Carcinomas.
Shakeri S; Raman SS
Radiol Clin North Am; 2020 Sep; 58(5):981-993. PubMed ID: 32792128
[TBL] [Abstract][Full Text] [Related]
4. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
5. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
[TBL] [Abstract][Full Text] [Related]
6. Treatment for T1a Renal Cancer Substratified by Size: "Less is More".
Moskowitz D; Chang J; Ziogas A; Anton-Culver H; Clayman RV
J Urol; 2016 Oct; 196(4):1000-7. PubMed ID: 27113965
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of image-guided ablation and laparoscopic partial nephrectomy for T1 renal cell carcinoma.
Chan VW; Osman FH; Cartledge J; Gregory W; Kimuli M; Vasudev NS; Ralph C; Jagdev S; Bhattarai S; Smith J; Lenton J; Wah TM
Eur Radiol; 2022 Sep; 32(9):5811-5820. PubMed ID: 35384457
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
Uhlig A; Uhlig J; Trojan L; Kim HS
J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
[TBL] [Abstract][Full Text] [Related]
9. Treatment of localised renal cell carcinoma.
Van Poppel H; Becker F; Cadeddu JA; Gill IS; Janetschek G; Jewett MA; Laguna MP; Marberger M; Montorsi F; Polascik TJ; Ukimura O; Zhu G
Eur Urol; 2011 Oct; 60(4):662-72. PubMed ID: 21726933
[TBL] [Abstract][Full Text] [Related]
10. Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.
Long JA; Bernhard JC; Bigot P; Lanchon C; Paparel P; Rioux-Leclercq N; Albiges L; Bodin T; Nouhaud FX; Boissier R; Gimel P; Méjean A; Masson-Lecomte A; Grenier N; Cornelis F; Grassano Y; Comat V; Le Clerc QC; Rigaud J; Salomon L; Descotes JL; Sengel C; Roupret M; Verhoest G; Ouzaid I; Arnoux V; Bensalah K;
World J Urol; 2017 Apr; 35(4):649-656. PubMed ID: 27498139
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
12. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous ablation techniques for renal cell carcinoma: current status and future trends.
Filippiadis D; Mauri G; Marra P; Charalampopoulos G; Gennaro N; De Cobelli F
Int J Hyperthermia; 2019 Oct; 36(2):21-30. PubMed ID: 31537160
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors.
Ahrar K; Wallace MJ; Matin SF
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1735-44. PubMed ID: 17181487
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
17. [Percutaneous radiofrequency ablation of renal cell cancer].
Tacke J; Mahnken AH
Radiologe; 2004 Apr; 44(4):358-63. PubMed ID: 15048557
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
Rembeyo G; Correas JM; Jantzen R; Audenet F; Dariane C; Delavaud C; Mejean A; Timsit MO
Clin Genitourin Cancer; 2020 Apr; 18(2):138-147. PubMed ID: 31982346
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation using real-time ultrasonography-computed tomography fusion imaging improves treatment outcomes for T1a renal cell carcinoma: Comparison with laparoscopic partial nephrectomy.
Chung DJ; Hwang H; Sohn DW
Investig Clin Urol; 2022 Mar; 63(2):159-167. PubMed ID: 35244989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
